NXN 188

· NeurAxon Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NXN 188, covering 2009-07-28 to 2014-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of NXN 188 for the Treatment of Migraine With Aura [Phase 2]